Lebwohl M, Blauvelt A, Menter A, Papp K, Jacobson A. Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab. J of Skin [Internet]. 2019Nov.9 [cited 2024May1];3:S26. Available from: https://www.jofskin.org/index.php/skin/article/view/753